Advy
Ashwini Doke is an experienced professional in the pharmaceutical regulatory affairs sector, currently serving as an Executive in regulatory affairs at Advy since September 2023. Prior roles include RA Officer at Kilitch Company (Pharma) Limited from July 2022 to September 2023, and positions at FDC Limited as an Analytical Officer and Trainee Officer between November 2020 and May 2020. Ashwini's career began as a Project Trainee at Watson Pharma Pvt Ltd from July 2018 to January 2019. Academically, Ashwini obtained a Master of Pharmacy in Quality Assurance from Amrutvahini Sheti & Vikas Santhas College of Pharmacy and a Bachelor of Pharmacy from the same institution, with additional education from Sahyadri Bahujan Vidya Prasarak Samajs Sahakarmaharshi Bhausaheb Santuji Thorat College of Arts, Science & Commerce.
This person is not in any teams
Advy
We are a global manufacturer of products expanding beyond Native Human Antigens (Purified Proteins) and Polyclonal Antibodies; Diagnostic kits with Rapid Diagnostic Tests, Slide & TurbiLatex reagents, and strives to ensure customized quality products are delivered to IVD manufacturers and suppliers across the world. Consistently high quality, reproducible results and a flexible approach to address the needs of each customer has helped us to emerge as the provider of choice to IVD manufacturers’ world over. Advy exports its products around the world, significantly to USA, Europe, Japan, and China. On the back of a successful reputation and a growing base of experiential knowledge, Advy also entered into the Indian market since 2010. We lead the global market in the production of C Reactive Protein – an inflammatory biomarker, Alpha 1-microglobulin – a renal biomarker, and produce a wide range of polyclonal antibody products. The antibodies for these products are raised in goats against various human proteins from its ISO 9001 and CPCSEA compliant animal farm. We also have the necessary expertise to manufacture diagnostic test kits. The rapid range of diagnostic test kits includes Malaria Antigen Rapid Tests and Dengue Rapid Diagnostic Tests. The Advy facility is compliant to EN ISO 13485 and to GMP manufacturing practices.